ECDC and World Health Organization (WHO) Regional Office for Europe have jointly developed the European Respiratory Virus Surveillance Summary (ERVISS), an interactive surveillance data dashboard for influenza, respiratory syncytial virus (RSV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that also features a weekly epidemiological summary.
This report is based on the findings from two focused After-Action reviews (AARs) in Norway and Georgia that discussed the use of evidence in the advice-making process for long-term care facilities (LTCFs) during the start of the COVID-19 Omicron wave in early 2022.
As autumn moves to winter, the WHO/Europe, EC and ECDC are issuing a clear, urgent message: people who remain unprotected against both COVID-19 and seasonal influenza – especially the most vulnerable and at-risk – should take up any offer for vaccination to prevent or mitigate the impact of these co-circulating respiratory infections.
The public health advice-making process on schools in Sweden during the COVID-19 pandemic from November 2020 to April 2021 has undergone an After-Action Review (AAR), with results now available in a new report by ECDC and the Public Health Agency of Sweden, Folkhälsomyndigheten.
This after-action review (AAR) investigates the use of evidence in Sweden’s advice-making process for distance learning during the period November 2020 to April 2021 (the focus period) in response to the SARS-CoV-2 (COVID-19) pandemic.
In a technical report published today, ECDC, proposes a targeted testing approach in areas with ongoing avian influenza outbreaks in poultry and detections in wild birds and other animals, focusing on severe respiratory or unexplained neurological disease.